Cite
P1‐449: MAPPING AMYLOID DEPOSITION ON CORTICAL ATROPHY IN DOWN SYNDROME: A COMBINED BASELINE AND 2‐YEAR LONGITUDINAL ANALYSIS.
MLA
Mak, Elijah, et al. “P1‐449: Mapping Amyloid Deposition on Cortical Atrophy in Down Syndrome: A Combined Baseline and 2‐Year Longitudinal Analysis.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 14, July 2018, pp. P487–88. EBSCOhost, https://doi.org/10.1016/j.jalz.2018.06.458.
APA
Mak, E., Padilla, C., Annus, T., Wilson, L., Hong, Y. T., Acosta-Cabronero, J., Fryer, T. D., Cardenas-Blanco, A., Boros, I., Coles, J. P., Aigbirhio, F. I., Menon, D. K., Nestor, P., Zaman, S., & Holland, A. J. (2018). P1‐449: Mapping Amyloid Deposition on Cortical Atrophy in Down Syndrome: A Combined Baseline and 2‐Year Longitudinal Analysis. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 14, P487–P488. https://doi.org/10.1016/j.jalz.2018.06.458
Chicago
Mak, Elijah, Concepcion Padilla, Tiina Annus, Liam Wilson, Young T. Hong, Julio Acosta-Cabronero, Tim D. Fryer, et al. 2018. “P1‐449: Mapping Amyloid Deposition on Cortical Atrophy in Down Syndrome: A Combined Baseline and 2‐Year Longitudinal Analysis.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 14 (July): P487–88. doi:10.1016/j.jalz.2018.06.458.